High-yield points
- Shunt survival: randomized trial 52% vs 50% at 2 years, no difference . Cochrane RR 1.02 . HCRN: programmability and valve type don't predict failure .
- Flow-regulated (Orbis-Sigma) valves: French series suggest longer survival (49% at 20 years, better than differential-pressure valves) and fewer slit ventricles. The randomized shunt design trial found no difference .
- Observational meta-analyses suggest fewer revisions (RR 0.56) and fewer drainage complications with programmable valves, but they are prone to bias .
- Main advantage: pressure can be adjusted without surgery. This helps most with over- or under-drainage and in complex patients like preterm posthemorrhagic hydrocephalus .
- MRI: setting changes follow 27–57% of MRIs and vary by brand, from about 74% (Strata) to 0% (Strata MR, proGAV 2.0). Check before and after every MRI .
- Everyday devices: risk exists only very close to the valve, mainly from magnetic toys and a tablet within about 2.5 cm. Headphones and phones used normally are safe .
- Head growth in infants: programmable or adjustable valves can be used to counteract excessive head growth and to treat over- or under-drainage as the child grows . Overdrainage can instead cause craniocerebral disproportion .
- Head size and survival: a larger head at shunting predicts malfunction (HC >27 cm in posthemorrhagic hydrocephalus) and early complications . Extreme macrocephaly carries high rates of wound breakdown, infection and death .
Landmark papers
- Programmable valve trial (Pollack et al., Neurosurgery 1999): the only randomized trial of programmable vs conventional valves (377 patients). Among the 235 first shunt insertions, the original shunt survived 2 years without revision in 52% vs 50% .
- Pediatric valve design trial (Drake et al., Neurosurgery 1998): a randomized trial in which the Orbis-Sigma valve, the Delta valve and standard differential-pressure valves had no difference in failure-free survival .
- Cochrane review (Garegnani et al., Cochrane Database Syst Rev 2020): rated the programmable comparison low-certainty evidence, with treatment failure of 52% in both arms (RR 1.02) .
Does programmability change shunt survival?
The best evidence says no. In the only randomized trial (377 patients), among the 235 first shunt insertions the original shunt survived 2 years without revision in 52% with a programmable Codman Hakim valve vs 50% with a conventional valve. For revisions the figures were 43% in each arm. Valve survival, overall shunt survival and control of hydrocephalus were all comparable . A Cochrane review rated this comparison as low-certainty evidence and found treatment failure of 52% in both arms (RR 1.02) and similar adverse events (6.19% vs 6.01%) . Large prospective HCRN cohorts agree: neither valve programmability nor valve type was independently associated with shunt failure.
Pooled analyses that include observational studies are more favorable to programmable valves, but they carry selection bias:
- One meta-analysis of 1,702 patients found fewer revisions (RR 0.56), fewer over- or under-drainage complications (RR 0.44) and fewer complications overall (RR 0.80) with programmable valves. The authors warned that bias and patient selection prevent a general conclusion .
- Another, of 2,622 patients, found no difference in 1-year shunt survival (RR 1.06), but fewer revisions (RR 0.56) and fewer over- or under-drainage complications (RR 0.55). The benefit appeared mainly in patients under 18 .
- In the opposite direction, one retrospective pediatric series found better 5-year survival with nonprogrammable valves (45.8% vs 19.8%) .
Flow-regulated valves (Orbis-Sigma)
The Orbis-Sigma valve (OSV) is neither programmable nor a simple differential-pressure valve. It regulates flow rather than pressure, to limit overdrainage. French series from Necker-Enfants Malades suggest it may give longer shunt survival:
- Long-term Necker cohort: in 975 children treated from 1985 to 1995 (mean follow-up 11 years), most initial shunts were OSVs.
- OSV shunt survival was 70% at 1 year, 58% at 10 years and 49% at 20 years.
- Event-free shunt survival was significantly higher than with classic differential-pressure valves (p = 0.009).
- Obstruction was the commonest mechanical failure (50.7%) .
- Earlier Necker comparison: in 343 children with an OSV vs 1,719 with standard differential-pressure valves:
- 1- and 5-year failure rates were 20.1% and 23.6% vs 31.1% and 49%.
- Slit ventricles occurred in 8.2% vs 33.2%.
- Valve obstruction was more common with the OSV (18.3% vs 9.7%), mostly early after surgery .
- European multicenter OSV II study: in 557 children and adults, 5-year survival was 62% and overdrainage occurred in only 1.8%. Survival was lower in infants under 6 months (55% at 5 years) .
The randomized evidence does not confirm a survival advantage:
- In the pediatric shunt design trial, the Orbis-Sigma valve, the Delta valve and standard differential-pressure valves had no difference in failure-free survival .
- The Cochrane review rated treatment failure as similar for standard and flow-regulating valves (43.0% vs 39.1%, low certainty) .
- In neonates and young infants, 1-year survival was similar for OSV and adjustable valves, but clinical overdrainage was less common with the OSV (24% vs 59%) .
Taken together, the French data suggest a possible long-term survival benefit and less overdrainage with flow regulation. Those data are nonrandomized and historical, and the randomized trial showed no difference .
Advantages of programmable valves
- Noninvasive adjustment: the setting can be changed with an external magnet instead of an operation. In 53 premature infants with posthemorrhagic hydrocephalus, 28 valves had at least one pressure change, and symptoms improved after 21 of them (75%). In 8 children switched from fixed to programmable valves, revisions fell by a mean of 1.9 per patient after the switch. Overall 12-month shunt survival was nevertheless the same (25.7% programmable vs 24.7% fixed) .
- Over- and under-drainage: in a 10-year pediatric series, programmable valves placed secondarily were most often placed for overdrainage. In that series, 44% of children needed at least one reprogramming. 90.9% of de novo programmable shunts were revision-free at 10 years, compared with 59.9% of secondary ones .
- Limits: for severe slit ventricle syndrome, reprogramming alone failed in 21 of 37 patients with programmable valves, who then needed surgery . In the randomized trial, the desired setting could not be achieved in 22 programmable valves, although most of those patients were doing well and were not reprogrammed .
Modulating head growth in infants
In infants with open sutures, the valve setting affects head growth as well as ventricular size. A programmable valve lets the surgeon adjust drainage as the head grows, rather than accept a single fixed setting:
- Limiting excessive head growth: 78 infants were shunted in the first year of life with a fixed differential-pressure valve plus an adjustable gravitational unit. Ventricular size fell and excessive head growth "could be counteracted effectively."
- Settings were adjusted in 31% of infants by 12 months, 42% by 24 months and 64% by last follow-up, successfully treating under- and over-drainage.
- Revision-free shunt survival was 79% at 12 months and 70% at 24 months .
- Deliberate temporary overdrainage: 40 infants under 1 year were drained more at first, then the valve was turned up once the wound had healed. The aim was to prevent wound breakdown, CSF fistula and subcutaneous CSF collections. No child showed overdrainage complications (premature suture closure, low-pressure syndrome, slit ventricle syndrome, subdural collections) during a mean follow-up of 2.6 years .
- Treating subdural collections without surgery: in the randomized programmable-valve trial, more than half of all setting changes were made in the first 3 months. Raising the opening pressure was used to treat 7 of 12 programmable-valve patients with subdural collections. Among patients with subdural collections, fewer with programmable valves needed the hematoma drained and the shunt removed (8.3% vs 36.3%). The overall incidence of subdural collections did not differ between valve types .
- The opposite risk, too little head growth: chronic overdrainage can dampen the CSF pulsations that drive normal skull growth. This can cause craniocerebral disproportion, in which the skull is too small for the brain, refractory to valve changes and needing cranial vault expansion . In infants with extreme macrocephaly (HC >49 cm), shunting can cause overlapping skull plates, secondary synostosis and severe cranial deformity from overdrainage .
Head size and shunt survival
- Larger heads predict more failure: in 102 infants with posthemorrhagic hydrocephalus followed for up to 30 years, a head circumference above 27 cm at shunting was independently associated with proximal and distal malfunction . In 125 infants shunted in Tanzania (mean HC 51.4 cm), a larger head circumference was a risk factor for early complications, mainly infection .
- Larger ventricles too: large ventricles were associated with a higher risk of malfunction (HR 2.33) in the pediatric valve design trial cohort .
- Extreme macrocephaly ("huge hydrocephalus"): when the HC exceeded body length, wound breakdown occurred in 17%, postoperative CSF infection in 33% and death in 33%. All children with a mean Evans index of 0.7 died within 12 months . Of 5 neonates with HC >49 cm shunted without cranial vault reduction, 3 developed severe cranial deformity .
- Practical implication: the thin, stretched scalp over a very large head and the risk of overdrainage-related collapse argue for careful wound technique and a cautious, adjustable approach to drainage .
Disadvantages and risks
- MRI can change the setting:
- In one series, the setting changed after 56.7% of MRIs. Changes were more common at higher field strength and with Medtronic Strata than Codman Hakim valves .
- In a 2026 series, the setting changed after 26.7% of MRIs, and brand was the dominant factor: Strata 73.7%, Polaris 30.9%, Certas Plus 12.2%, proGAV 10%, and Strata MR and proGAV 2.0 0% .
- Check the setting before and after every MRI . Valves that lack a locking mechanism change most often .
- Everyday magnets:
- Toy magnets reprogrammed Strata valves at up to 10–50 mm and Codman valves at up to 5–30 mm. Polaris valves were unaffected .
- A tablet computer within 1 cm changed 58% of valve settings, within 1–2.5 cm only 5%, and beyond 5 cm none .
- Headphones changed settings only on direct contact . Earbuds, headphones, tablets, phones and a VR headset, used realistically, changed none .
- Hidden costs: settings need confirming, usually with skull radiographs before and after MRI. One group suggests simply reprogramming to the preferred setting after MRI, to reduce radiation and cost .
Practical approach
- For a routine first shunt, either type is reasonable. A nonprogrammable differential-pressure valve is the simpler choice, since programmability does not improve survival .
- Consider a programmable valve when the right pressure is uncertain or likely to change, when there has been over- or under-drainage, or after repeated revisions in complex patients .
- If a programmable valve is used, know its brand and how vulnerable it is to MRI, check the setting before and after every MRI, and counsel families about strong magnets held directly against the valve .
Related topics
- Shunt Overdrainage and Slit Ventricle Syndrome: the main indication for reprogramming.
- Craniocerebral Disproportion: when chronic overdrainage limits skull growth.
- Shunt Failure: causes and diagnosis of malfunction.
- Surgical Options in Shunting: distal sites and shunt types.
- Intraventricular Hemorrhage of Prematurity and Posthemorrhagic Hydrocephalus: posthemorrhagic hydrocephalus in preterm infants.
- Ventriculoperitoneal Shunt Insertion: insertion.
References
- Pollack IF, Albright AL, Adelson PD. A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Neurosurgery 1999;45(6):1399–1408. doi:10.1097/00006123-199912000-00026. PMID 10598708. verified
- Garegnani L, Franco JV, Ciapponi A, et al. Ventriculo-peritoneal shunting devices for hydrocephalus. Cochrane Database Syst Rev 2020;6(6):CD012726. doi:10.1002/14651858.CD012726.pub2. PMID 32542676. verified
- Riva-Cambrin J, Kestle JR, Holubkov R, et al. Risk factors for shunt malfunction in pediatric hydrocephalus: a multicenter prospective cohort study. J Neurosurg Pediatr 2016;17(4):382–390. doi:10.3171/2015.6.PEDS14670. PMID 26636251. verified
- Ravindra VM, Kestle JRW, Jensen H, et al. Cerebrospinal fluid shunt failure in children is associated with medical complexity and shunt position, not shunt technology: a multicenter prospective study from the Hydrocephalus Clinical Research Network. J Pediatr 2026;300:115308. doi:10.1016/j.jpeds.2026.115308. PMID 42716243. verified
- Xu H, Wang ZX, Liu F, et al. Programmable shunt valves for the treatment of hydrocephalus: a systematic review. Eur J Paediatr Neurol 2013;17(5):454–461. doi:10.1016/j.ejpn.2013.04.001. PMID 23830575. verified
- Li M, Wang H, Ouyang Y, et al. Efficacy and safety of programmable shunt valves for hydrocephalus: a meta-analysis. Int J Surg 2017;44:139–146. doi:10.1016/j.ijsu.2017.06.078. PMID 28648796. verified
- Hatlen TJ, Shurtleff DB, Loeser JD, et al. Nonprogrammable and programmable cerebrospinal fluid shunt valves: a 5-year study. J Neurosurg Pediatr 2012;9(5):462–467. doi:10.3171/2012.1.PEDS10482. PMID 22546022. verified
- Hall BJ, Ali AMS, Hennigan D, et al. Hydrocephalus in prematurity: does valve choice make a difference? Childs Nerv Syst 2024;40(4):1091–1098. doi:10.1007/s00381-023-06204-8. PMID 37934253. verified
- Sordyl R, Wyroba N, Kardas N, et al. The application of programmable shunts in the management of hydrocephalus in pediatric patients. Childs Nerv Syst 2026;42(1). doi:10.1007/s00381-026-07210-2. PMID 41831117. verified
- Ucisik FE, Simonetta AB, Bonfante-Mejia EM. Magnetic resonance imaging-related programmable ventriculoperitoneal shunt valve setting changes occur often. Acta Neurochir (Wien) 2022;164(2):495–498. doi:10.1007/s00701-021-05060-2. PMID 34787715. verified
- O'Neill BE, Pfeuffer A, Soyland DJ, et al. Programmable shunt valve stability after MRI: a 2-year institutional experience across valve types and field strengths. Childs Nerv Syst 2026;42(1). doi:10.1007/s00381-026-07409-3. PMID 42562913. verified
- Zuzak TJ, Balmer B, Schmidig D, et al. Magnetic toys: forbidden for pediatric patients with certain programmable shunt valves? Childs Nerv Syst 2009;25(2):161–164. doi:10.1007/s00381-008-0770-x. PMID 19057906. verified
- Strahle J, Selzer BJ, Muraszko KM, et al. Programmable shunt valve affected by exposure to a tablet computer. J Neurosurg Pediatr 2012;10(2):118–120. doi:10.3171/2012.3.PEDS1211. PMID 22734456. verified
- Spader HS, Ratanaprasatporn L, Morrison JF, et al. Programmable shunts and headphones: are they safe together? J Neurosurg Pediatr 2015;16(4):402–405. doi:10.3171/2015.1.PEDS14400. PMID 26149436. verified
- Park M, Chaudhry M, Quadri N, et al. Impact of handheld and wearable electronics on programmable shunt valves. J Neurosurg Pediatr 2026;38(3):335–340. doi:10.3171/2026.2.PEDS25125. PMID 42398102. verified
- Auricchio AM, Bohnen A, Nichelatti M, et al. Management of slit ventricle syndrome: a single-center case series of 32 surgically treated patients. World Neurosurg 2022;158:e352–e361. doi:10.1016/j.wneu.2021.10.183. PMID 34749014. verified
- Bock HC, von Philipp G, Ludwig HC. An adjustable gravitational valve for initial VP-shunt treatment in hydrocephalic preterm neonates and infants below 1 year of age. Childs Nerv Syst 2021;37(11):3497–3507. doi:10.1007/s00381-021-05250-4. PMID 34152450. verified
- Korinth MC, Weinzierl MR, Gilsbach JM. Experience with a new concept to lower non-infectious complications in infants with programmable shunts. Eur J Pediatr Surg 2003;13(2):81–86. doi:10.1055/s-2003-39585. PMID 12776237. verified
- Carmel PW, Albright AL, Adelson PD, et al. Incidence and management of subdural hematoma/hygroma with variable- and fixed-pressure differential valves: a randomized, controlled study of programmable compared with conventional valves. Neurosurg Focus 1999;7(4):e7. doi:10.3171/foc.1999.7.4.2. PMID 16918220. verified
- Martínez-Lage JF, Ruiz-Espejo Vilar A, Pérez-Espejo MA, et al. Shunt-related craniocerebral disproportion: treatment with cranial vault expanding procedures. Neurosurg Rev 2006;29(3):229–235. doi:10.1007/s10143-006-0022-z. PMID 16534633. verified
- Iyer RR, Carey CM, Rottgers SA, et al. Early postnatal cranial vault reduction and fixation surgery for severe hydrocephalic macrocephaly. J Neurosurg Pediatr 2018;21(5):486–495. doi:10.3171/2017.11.PEDS17173. PMID 29498604. verified
- Bir SC, Konar S, Maiti TK, et al. Outcome of ventriculoperitoneal shunt and predictors of shunt revision in infants with posthemorrhagic hydrocephalus. Childs Nerv Syst 2016;32(8):1405–1414. doi:10.1007/s00381-016-3090-6. PMID 27278283. verified
- Santos MM, Rubagumya DK, Dominic I, et al. Infant hydrocephalus in sub-Saharan Africa: the reality on the Tanzanian side of the lake. J Neurosurg Pediatr 2017;20(5):423–431. doi:10.3171/2017.5.PEDS1755. PMID 28885096. verified
- Tuli S, O'Hayon B, Drake J, et al. Change in ventricular size and effect of ventricular catheter placement in pediatric patients with shunted hydrocephalus. Neurosurgery 1999;45(6):1329–1333. doi:10.1097/00006123-199912000-00012. PMID 10598700. verified
- Deora H, Thakur D, Shashidhar A, et al. Huge hydrocephalus: a rare case series with insights into management and outcomes of this neglected cohort. Childs Nerv Syst 2024;40(9):2905–2914. doi:10.1007/s00381-024-06495-5. PMID 38898287. verified
- Beuriat PA, Puget S, Cinalli G, et al. Hydrocephalus treatment in children: long-term outcome in 975 consecutive patients. J Neurosurg Pediatr 2017;20(1):10–18. doi:10.3171/2017.2.PEDS16491. PMID 28430083. verified
- Sainte-Rose C. Shunt obstruction: a preventable complication? Pediatr Neurosurg 1993;19(3):156–164. doi:10.1159/000120722. PMID 8499327. verified
- Hanlo PW, Cinalli G, Vandertop WP, et al. Treatment of hydrocephalus determined by the European Orbis Sigma Valve II survey: a multicenter prospective 5-year shunt survival study in children and adults in whom a flow-regulating shunt was used. J Neurosurg 2003;99(1):52–57. doi:10.3171/jns.2003.99.1.0052. PMID 12854744. verified
- Drake JM, Kestle JR, Milner R, et al. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 1998;43(2):294–303. doi:10.1097/00006123-199808000-00068. PMID 9696082. verified
- Henderson D, Budu A, Zaki H, et al. A comparison between flow-regulated and adjustable valves used in hydrocephalus during infancy. Childs Nerv Syst 2020;36(9):2013–2019. doi:10.1007/s00381-020-04552-3. PMID 32152667. verified
Verification (2026-10-23): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every figure cited was checked against the PubMed abstract. Full texts were not reviewed. The "Practical approach" section and the practical implication of head size are this text's synthesis of the cited evidence, not a published guideline.